In Treatment of Abdominal pain Byspas 20mg/325mg Tablet effectively relieves sudden muscle spasms or contractions in the stomach and intestine (gut), thereby relaxing the muscles and improving the movement of food. It also blocks chemical messengers in the brain that are responsible for pain sensation. This helps to treat abdominal pain (or stomach pain) as well as cramps, bloating, and discomfort. Take Byspas 20mg/325mg Tablet as prescribed to get maximum benefit. Eventually, it will help you to go about your daily activities more easily and have a more active and better quality of life.
It is unsafe to consume alcohol with Byspas 20mg/325mg Tablet.
Byspas 20mg/325mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Byspas 20mg/325mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Byspas 20mg/325mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Byspas 20mg/325mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Byspas 20mg/325mg Tablet may be needed. Please consult your doctor.
Byspas 20mg/325mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Byspas 20mg/325mg Tablet may be needed. Please consult your doctor. However, the use of Byspas 20mg/325mg Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Byspas 20mg/325mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Geno Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Asvins Lifecare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nemi Pharmaceuticles || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Akme Biotec || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elixir Life Care Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wockhardt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Truecure Healthcare Private Limited || ₹14.5/tablet (25% cheaper)